H 50mg / Z 150mg / R 75mg, disp. tab., blister
STD
DORAHZRI5TD1
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
22/10/2024, 12:20:19
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AM05
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit.
A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
ISONIAZID (H) / PYRAZINAMIDE (Z) / RIFAMPICIN (R)
Therapeutic Action
Fixed-dose combination (FDC) of three bactericide antituberculosis
Indications
Drug-Sensitive Tuberculosis (DS-TB)
Instructions for use
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
The quantity to be ordered is calculated per tablet, not per blister.
Storage
Below 25°C ‐ Protect from sunlight ‐ Protect from humidity